Vetr's Top Raters Bullish On Juno Therapeutics

By: via Benzinga
Shares of Juno Therapeutics Inc (NASDAQ: JUNO) are down more than 9 percent year-to-date, having underperformed the Nasdaq 100 and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.